Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald F Smee

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Antiviral Research|August 27, 2011
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander, Joe Hagloch, Scott Latimer, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|April 13, 2004
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard, Valerie D Hubbard, Jared Burton, et al.
Antiviral Research|July 17, 2010
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Research|May 23, 2006
Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in miceDonald F Smee, Miles K Wandersee, Kevin W Bailey, et al.
Plos One|February 1, 2012
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesJack T Nguyen, Donald F Smee, Dale L Barnard, et al.
Antiviral Research|July 8, 2008
Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-NDonald F Smee, Kevin W Bailey, Min-Hui Wong, et al.
Journal of Virological Methods|April 1, 2017
Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic propertiesDonald F Smee, Brett L Hurst, W Joseph Evans, et al.
Antiviral Research|September 16, 2021
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challengeScott Parker, June D'Angelo, R Mark Buller, et al.
Virology|October 27, 2009
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day, Ralph Baric, Sui Xiong Cai, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Antiviral Research|August 27, 2011
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander, Joe Hagloch, Scott Latimer, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|April 13, 2004
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard, Valerie D Hubbard, Jared Burton, et al.
Antiviral Research|July 17, 2010
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Research|May 23, 2006
Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in miceDonald F Smee, Miles K Wandersee, Kevin W Bailey, et al.
Plos One|February 1, 2012
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesJack T Nguyen, Donald F Smee, Dale L Barnard, et al.
Antiviral Research|July 8, 2008
Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-NDonald F Smee, Kevin W Bailey, Min-Hui Wong, et al.
Journal of Virological Methods|April 1, 2017
Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic propertiesDonald F Smee, Brett L Hurst, W Joseph Evans, et al.
Antiviral Research|September 16, 2021
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challengeScott Parker, June D'Angelo, R Mark Buller, et al.
Virology|October 27, 2009
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day, Ralph Baric, Sui Xiong Cai, et al.
Pageof 13